Ternant, David
Azzopardi, Nicolas
Raoul, William
Bejan-Angoulvant, Theodora
Paintaud, Gilles
Article History
First Online: 26 May 2018
Compliance with Ethical Standards
:
: This work was partly supported by the French Higher Education and Research Ministry under the program ‘Investissements d’avenir’ Grant Agreement: LabEx MAbImprove ANR-10-LABX-53-01.
: David Ternant has given lectures for Amgen and Sanofi. Gilles Paintaud reports grants received by his research team, from Novartis, Roche Pharma, Sanofi-Genzyme, Chugai and Pfizer, outside of the submitted work. Theodora Bejan-Angoulvant, William Raoul and Nicolas Azzopardi have no conflicts of interest directly relevant to the content of this article.